Search for:
About Zealand
About Us
Disease Focus
History
Corporate Management
Corporate Governance
Corporate Social Responsibility
Board of Directors
Videos About Zealand
Transparency Reporting
R&D
Our Focus
Product Pipeline
Glepaglutide for SBS
Dasiglucagon for BHAP Systems
Dasiglucagon for CHI
BI 456906 GLP-1/GLU Dual Agonist
Amylin Analogue, ZP8396
In-licensing
What are Peptides?
Peptide Platform Video
Investor
Investor Relations
Corporate Presentation
Stock Information
Shareholder Portal
Financial Calendar
Financial Reports
Events
Annual General Meeting
Conference Calls
SEC Filings
Analyst Coverage
Media
Zealand News
Media Inquiry
Downloads
Careers
Zealand as a Workplace
Meet Us
Positions
Personal Data in the Recruitment Process
Contact
Zealand News
Media Inquiry
Downloads
Downloads
Corporate Management
Adam Steensberg, President and Chief Executive Officer
Christina Sonnenborg Bredal, Senior Vice President and Global Head of People & Organization
David Kendall, Chief Medical Officer
Henriette Wennicke, Chief Financial Officer
Ivan Møller, Executive Vice President and Chief Operating Officer
Ravinder Chahil, Vice President and General Counsel
Research and Development
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
For Press RGB_01.eps
